Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review
- PMID: 33637354
- DOI: 10.1016/j.jacc.2020.12.065
Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease: JACC State-of-the-Art Review
Abstract
Metabolic perturbations underlie a variety of cardiovascular disease states; yet, metabolic interventions to prevent or treat these disorders are sparse. Ketones carry a negative clinical stigma as they are involved in diabetic ketoacidosis. However, evidence from both experimental and clinical research has uncovered a protective role for ketones in cardiovascular disease. Although ketones may provide supplemental fuel for the energy-starved heart, their cardiovascular effects appear to extend far beyond cardiac energetics. Indeed, ketone bodies have been shown to influence a variety of cellular processes including gene transcription, inflammation and oxidative stress, endothelial function, cardiac remodeling, and cardiovascular risk factors. This paper reviews the bioenergetic and pleiotropic effects of ketone bodies that could potentially contribute to its cardiovascular benefits based on evidence from animal and human studies.
Keywords: cardiovascular disease; heart failure; ketones; pleiotropic effects.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The UMCG, which employs Drs. Yurista, de Boer, and Westenbrink, has received research grants and/or fees from Abbott, AstraZeneca, Bristol Myers Squibb, Novartis, Novo Nordisk, and Roche. Dr. Chong is supported by a fellowship jointly awarded by the National Health & Medical Research Council (GNT1162356) and National Heart Foundation of Australia (102126). Dr. Kelly is supported by NIH R01 HL058493, HL128349, and HL151345; and has served as a scientific consultant for Pfizer, Amgen, and Janssen. Dr. de Boer is supported by the Netherlands Heart Foundation (CVON DOUBLE DOSE, grant 2020-8005, CVON SHE-PREDICTS-HF, grant 2017-21, and CVON RED-CVD, grant 2017-11) and the European Research Council (ERC CoG 818715, SECRETE-HF); and has received personal fees from Abbott, AstraZeneca, Novartis, and Roche. Dr. Westenbrink is supported by the Netherlands Organisation for Scientific Research (NWO VENI, grant 016.176.147) and the Netherlands Heart Foundation Senior Clinical Scientist Grant (2019T064) and CVON DOUBLE DOSE (grant 2020-8005). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Similar articles
-
Ketones and the cardiovascular system.Nat Cardiovasc Res. 2023 May;2(5):425-437. doi: 10.1038/s44161-023-00259-1. Epub 2023 Apr 10. Nat Cardiovasc Res. 2023. PMID: 39196044 Review.
-
Ketones and the Heart: Metabolic Principles and Therapeutic Implications.Circ Res. 2023 Mar 31;132(7):882-898. doi: 10.1161/CIRCRESAHA.123.321872. Epub 2023 Mar 30. Circ Res. 2023. PMID: 36996176 Free PMC article. Review.
-
Myocardial Ketones Metabolism in Heart Failure.J Card Fail. 2020 Nov;26(11):998-1005. doi: 10.1016/j.cardfail.2020.04.005. Epub 2020 May 19. J Card Fail. 2020. PMID: 32442517 Review.
-
Metabolic and Signaling Roles of Ketone Bodies in Health and Disease.Annu Rev Nutr. 2021 Oct 11;41:49-77. doi: 10.1146/annurev-nutr-111120-111518. Annu Rev Nutr. 2021. PMID: 34633859 Free PMC article.
-
Ketone Bodies and Cardiovascular Disease: An Alternate Fuel Source to the Rescue.Int J Mol Sci. 2023 Feb 10;24(4):3534. doi: 10.3390/ijms24043534. Int J Mol Sci. 2023. PMID: 36834946 Free PMC article. Review.
Cited by
-
Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet-Pharmacotherapy Interactions.Nutrients. 2024 Apr 19;16(8):1213. doi: 10.3390/nu16081213. Nutrients. 2024. PMID: 38674903 Free PMC article. Review.
-
Ketone ester supplementation suppresses cardiac inflammation and improves cardiac energetics in a swine model of acute myocardial infarction.Metabolism. 2023 Aug;145:155608. doi: 10.1016/j.metabol.2023.155608. Epub 2023 Jun 1. Metabolism. 2023. PMID: 37268056 Free PMC article.
-
Mitochondrial quality control and transfer communication in neurological disorders and neuroinflammation.Front Immunol. 2025 Apr 28;16:1542369. doi: 10.3389/fimmu.2025.1542369. eCollection 2025. Front Immunol. 2025. PMID: 40356918 Free PMC article. Review.
-
Relationships Between Changes in Serum Ketone Body Levels and Metabolic Effects in Patients with Severe Obesity Who Underwent Laparoscopic Sleeve Gastrectomy.Obes Surg. 2024 Jul;34(7):2607-2616. doi: 10.1007/s11695-024-07337-8. Epub 2024 Jun 6. Obes Surg. 2024. PMID: 38842760 Free PMC article.
-
Mapping the Unseen: In Vivo CEST-MRI of Creatine Reveals Improved Cardiac Energetics in Subjects with Obesity Following Bariatric Surgery.Obes Surg. 2023 Jun;33(6):1944-1948. doi: 10.1007/s11695-023-06589-0. Epub 2023 Apr 14. Obes Surg. 2023. PMID: 37058265 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical